Provided by Tiger Fintech (Singapore) Pte. Ltd.

ResMed

281.50
-3.6750-1.29%
Volume:175.35K
Turnover:49.39M
Market Cap:41.22B
PE:29.60
High:285.09
Open:284.73
Low:279.63
Close:285.17
52wk High:293.81
52wk Low:199.92
Shares:146.41M
Float Shares:145.51M
Volume Ratio:0.89
T/O Rate:0.12%
Dividend:2.12
Dividend Rate:0.75%
EPS(TTM):9.51
EPS(LYR):9.55
ROE:25.86%
ROA:14.02%
PB:6.91
PE(LYR):29.48

Loading ...

ResMed FY2025 Q4 Earnings Call Summary and Q&A Highlights: Operational Efficiency and Digital Innovation Drive Growth

Earnings Call
·
Aug 05

Michael J. Rider, Global General Counsel, Reports Disposal of ResMed Inc. Common Shares

Reuters
·
Aug 05

ResMed RMD Q4 2025 Earnings Call Transcript

Motley Fool Transcribing
·
Aug 05

ResMed earnings: Solid showing from ASX healthcare winner

Morning Star AU
·
Aug 05

Analysts Offer Insights on Healthcare Companies: Sigma Healthcare Ltd (S5YA) and Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (ASX: AU:RMD)

TIPRANKS
·
Aug 04

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) Gets a Buy from Ord Minnett

TIPRANKS
·
Aug 04

ResMed CFO, Chief Legal Officer Sells Shares

MT Newswires Live
·
Aug 04

ResMed Inc Announces Proposed Sale of Common Shares

TIPRANKS
·
Aug 04

Resmed Inc-144 Report of Proposed Sale of Securities

THOMSON REUTERS
·
Aug 04

144 Report of proposed sale of securities-RMD.N

Reuters
·
Aug 04

Resmed Inc-Departure of Directors or Certain Officers

THOMSON REUTERS
·
Aug 04

Departure of Directors or Certain Officers-RMD.N

Reuters
·
Aug 04

ResMed Full Year 2025 Earnings: EPS Beats Expectations

Simply Wall St.
·
Aug 03

Top Traditional IRA Mistakes and How to Avoid Them

Motley Fool
·
Aug 03

How Much Is the Required Minimum Distribution (RMD) if You Have $500,000 in Your Retirement Accounts?

Motley Fool
·
Aug 03

Analysts Offer Insights on Healthcare Companies: Bausch + Lomb Corporation (BLCO), Resmed (RMD) and Envista Holdings (NVST)

TIPRANKS
·
Aug 02

ResMed Inc. Releases Transcript of FY 2025 Earnings Webcast

Reuters
·
Aug 02

ResMed Is Maintained at Overweight by Keybanc

Dow Jones
·
Aug 01

ResMed price target raised to $270 from $240 at Stifel

TIPRANKS
·
Aug 01

ResMed price target raised to $270 from $248 at Piper Sandler

TIPRANKS
·
Aug 01